New scan spots chemo damage to heart and muscles early
NCT ID NCT05731375
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a special MRI scan (31P-MRS) can detect early signs of damage to heart and muscle cells caused by chemotherapy drugs like doxorubicin. Twelve cancer patients scheduled for chemo underwent three scans over time. The goal was to see if the scan could measure changes in energy production inside cells, which might help doctors catch problems before they become serious.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a non-invasive way to detect early chemotherapy-related heart and muscle damage, helping doctors adjust treatment sooner.
What could go wrong
This is a very small, completed observational study with only 12 participants. It does not test any treatment, so it may not lead to direct patient benefits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Diakonessenhuis
Utrecht, Utrecht, 3582 KE, Netherlands
-
Meander Medisch Centrum
Amersfoort, Utrecht, 3813 TZ, Netherlands
-
UMC Utrecht
Utrecht, Utrecht, 3584CX, Netherlands
-
Ziekenhuis Gelderse Vallei
Ede, Gelderland, 6716 RP, Netherlands